To determine the temporal relationship between alcohol-induced changes in cytokines and chemokines, development of liver pathology and stimulation of hepatocyte proliferation, male Sprague-Dawley rats were intragastrically fed low carbohydrate-containing ethanol (EtOH) diets via total enteral nutrition (TEN) for up to 49 d. Induction of EtOH metabolism and appearance of steatosis preceded development of oxidative stress, inflammation, and cell death. A transitory peak of tumor necrosis factor (TNFα) and interferon gamma (IFNγ) was observed at 14 d followed by reduced expression of TNFα, IFNγ and another Th1 cytokine IL-12 accompanied by reduced expression of the Th1 regulators T-bet and STAT4. After 35–49 d of EtOH, at a time when hepatocyte proliferation was stimulated, IL-12 returned to control values and a second peak of TNFα occurred. The Th2 cytokine IL-4 remained suppressed throughout the study and was accompanied by reductions in the Th2 regulator GATA3. There was no temporal effect of EtOH on expression of IL-6 or TGFβ. IL-5 and IL-13 mRNA were undetectable. Chemokine CXCL-2 expression increased progressively up to 35 d and preceded the appearance of inflammatory infiltrates. These data suggest that steatosis, increased ethanol metabolism, a transient induction of the innate immune response and suppression of Th2 responses were acute consequences of ethanol treatment and were followed by suppression of Th1 responses. However, the majority of necrosis, apoptosis and a late peak of TNFα only occurred after 6–7 weeks of ethanol, coincided with the appearance of inflammatory infiltrates and were associated with stimulation of hepatocyte proliferation.
Get full access to this article
View all access options for this article.
References
1.
Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med343:1147–1476, 2000.
Nanji AA, Zhao S, Sadrazadeh SMH, Waxman DJ. Use of reverse transcription polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology19: 1483–1487, 1994.
4.
Kamimura S, Tsukomoto H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology21:1304–1309, 1995.
5.
Fang C, Lindros KO, Badger TM, Ronis MJJ, Ingelman-Sundberg M. Zonated expression of cytokines in rat liver: effect of chronic ethanol and the cytochrome P450 2E1 inhibitor chlormethiazole. Hepatology27:1304–1310, 1998.
6.
Neuman MG. Cytokines – central factors in alcoholic liver disease. Alcohol Res & Health27:307–315, 2003.
7.
McClain CJ, Brave S, Deacluc I, Kugelmas M, Hill D. Cytokines in alcoholic liver disease. Semin Liver Dis19:205–219, 1999.
8.
Crews FT, Bachara R, Brown LA, Guidot DM, Mandrekar P, Oak S, Qin L, Szabo G, Wheeler M, Zou J. Cytokines and alcohol. Alcohol Clin Exp Res30:720–730, 2006.
9.
Nanji AA, Jokelainen K, Rahemtulla A, Miao L, Fogt F, Matsumoto H, Tahan SR, Su GL. Activation of nuclear factor kappa B and cytokine inbalance in experimental alcoholic liver disease in the rat. Hepatology30:934–943, 1999.
10.
Kremer M, Hines IN, Milton RJ, Wheeler MD. Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis. Hepatology44:216–227, 2006.
11.
Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA94: 1441–1446, 1997.
12.
Isayama F, Froh M, Yin M, Conzelmann LO, Milton RJ, McKim SE, Wheeler MD. TNFα-induced Ras activation due to ethanol promotes hepatocyte proliferation independently of liver injury in the mouse. Hepatology39:721–731, 2004.
13.
Chiu H, Gardner CR, Dambach DM, Durham SK, Brittingham JA, Laskin JD, Laskin DL. Role of tumor necrosis factor receptor 1 (P55) in hepatocyte proliferation during acetaminophen-induced toxicity in mice. Toxicol Appl Pharmacol193:218–227, 2003.
14.
Thiele GM, Mandreckar P, Zakhari S, Hoek J, Cook RT, Ray NB, Happel KI, Kolls JK, Kovaks EJ, Szabo G. RSA 2004: combined basic research satellite symposium – mechanisms of alcohol mediated organ and tissue damage. Alcohol Clin Exp Res29:1735–1743, 2005.
15.
Bautista AP. Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease. J Gastrointest Hepatol15:349–356, 2000.
16.
Fisher NC, Neil DA, Williams A, Adams DH. Serum concentrations and peripheral secretion of the beta chemokines monocyte chemo-attractant protein 1 and macrophage inflammatory protein 1 alpha in alcoholic liver disease. Gut45:416–420, 1999.
17.
Nanji AA, Jokelainen K, Fotouhninia M, Rahemtulla A, Thomas P, Tiptoe GI, Su G, Dannenberg AJ. Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin and chemokines. Am J Physiol Gastrointest Liver Physiol281:G1348–G1356, 2001.
18.
Jaeschke H. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol27:23–27, 2002.
19.
Keegan A, Martini R, Batey R. Ethanol-induced liver injury in the rat: a model of steatosis, inflammation and pericentral fribrosis. J Hepatol23: 591–600, 1995.
20.
Ronis MJJ, Lumpkin CK, Ingelman-Sundberg M, Badger TM. Effects of short term ethanol and nutrition on the hepatic microsomal monooxygenase system in a model utilizing total enteral nutrition. Alcohol Clin Exp Res15:693–699, 1991.
21.
Badger TM, Ronis MJJ, Lumpkin CK, Valentine CR, Shahare M, Irby D, Huang J, Mercado C, Thomas PE, Ingelman-Sundberg M, Crouch J. Effects of chronic ethanol on growth hormone secretion and hepatic cytochrome P450 isozymes of the rat. J Pharmacol Exp Ther264:438–447, 1993.
22.
Korourian S, Hakkak R, Ronis MJJ, Shelnutt SR, Waldren J, Ingelman-Sundberg M, Badger TM. Diet and the risk of ethanol-induced hepatotoxicity: carbohydrate-fat relationships in rats. Toxicol Sci47: 110–117, 1999.
23.
Ronis MJJ, Hakkak R, Korourian S, Albano E, Yoon S, Ingelman-Sundberg M, Lindros KO, Badger TM. Alcoholic liver disease in rats fed ethanol as part of oral or intragastric low-carbohydrate diets. Exp Biol Med229:351–360, 2003.
24.
Ronis MJJ, Korourian S, Yoon S, Ingelman-Sundberg M, Albano E, Lindros KO, Badger TM. Lack of sexual dimorphism in alcohol-induced liver damage (ALD) in rats treated chronically with ethanol-containing low carbohydrate diets: the role of ethanol metabolism and endotoxin. Life Sci75:469–483, 2004.
25.
Ronis MJJ, Butura A, Sampey BP, Shankar S, Prior RL, Korourian S, Albano E, Ingelman-Sundberg M, Petersen DR, Badger TM. Effects of N-acetlycysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition. Free Radic Biol Med39:619–630, 2005.
26.
Badger TM, Hoog J-O, Svensson S, McGehee RE Jr, Ronis MJJ, Ingelman-Sundberg, M. Cyclic variation in class I alcohol dehydrogenase in male rats treated with ethanol. Biochem Biophys Res Commun274:684–688, 2000.
27.
Greenwell A, Foley JF, Maronpot RR. An enhancement method for immunohistochemical staining of proliferating cell nuclear antigen in archival rodent tissues. Cancer Lett54:251–256, 1991.
28.
Tsukamoto H, French SW, Reidelberger RD, Largman C. Cyclical pattern of blood alcohol levels during continuous intragastric ethanol infusion in rats. Alcohol Clin Exp Res9:31–37, 1985.
29.
Badger TM, Crouch J, Irby D, Hakkak R, Shahare M. Episodic excretion of ethanol during chronic intragastric ethanol infusion in the rat: continuous vs. cyclic ethanol and nutrient infusions. J Pharmacol Exp Ther264:938–943, 1993.
30.
Badger TM, Ronis MJJ, Ingelman-Sundberg M, Hakkak R. Inhibition of CYP 2E1 activity does not abolish pulsatile urine alcohol concentrations during alcohol infusions. Eur J Biochem230:914–919, 1995.
31.
Arteel GE. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology124:779–790, 2003.
32.
Lin HZ, Yang SG, Zeidin G, Diehl AM. Chronic ethanol consumption induces the production of tumor necrosis factor-α and related cytokines in liver and adipose tissue. Alcohol Clin Exp Res (5 Suppl.) 231S–237S, 1998.
33.
Pritchard MT, Nagy LE. Ethanol-induced liver injury: potential role for Egr-1. Alcohol Clin Exp Res29:146S–150S, 2005.
34.
Thurman RG. Mechanisms of hepatic toxicity II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol Gastrointest Liver Physiol275: G605–G611, 1998.
35.
Minagawa M, Deng Q, Liu Z-X, Tsukamoto H, Dennert G. Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-α during alcohol consumption. Gastroenterology126:1387–1399, 2004.
36.
Batey RG, Cao Q, Gould B. Lymphocyte-mediated liver injury in alcohol-related hepatitis. Alcohol27:37–41, 2002.
37.
Roncarolo MG, Baccetta R, Bordignon C, Narula S, Levings MK. Type 1 regulatory T cells. Immunol Rev182:68–79, 2001.
38.
Laso FJ, Vaquero JM, Almeida J, Marcos M, Orfao A. Production of inflammatory cytokines by peripheral blood monocytes in chronic alcoholism: relationship with ethanol intake and liver disease. Cytometry B Clin Cytom72:408–415, 2007.
39.
Mottaran E, Stewart SF, Rolla R, Vay D, Cipriani V, Moretti M, Vidali M et al. Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Free Radic Biol Med32:38–45, 2002.
40.
Kato A, Yoshidome H, Edwards MJ, Lentsch AB. Reduced hepatic ischemia/reperfusion injury by IL-4: a potential anti-inflammatory role for STAT6. Inflamm Res 2000 ; 49:275–279.
41.
La Flamme AC, Patton EA, Bauman B, Pearce EJ. IL-4 plays a crucial role in regulating oxidative damage in the liver during schistosomiasis. J Immunol166:1903–1911, 2001.
42.
Tsukamoto H, Towner SJ, Ciofalo LM, French SW. Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology6:814–822, 1986.
43.
Joshi-Barve S, Barve SS, Butt W, Klein J, McClain CJ. Inhibition of proteasome function leads to NF-κB-independent IL-8 expression in human hepatocytes. Hepatology38:1178–1187, 2003.
44.
Jerva LF, Sullivan G, Lolis E. Functional and receptor binding characterization of recombinant murine macrophage inflammatory protein 2: sequence analysis and mutagenesis identify receptor binding epitopes. Protein Sci6:1643–1652, 1997.
45.
Yamada Y, Fausto N. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type I but not type 2 tumor necrosis factor receptor. Am J Pathol152:1577–1589, 1998.
46.
Baumgardner JN, Shankar K, Korourian S, Badger TM, Ronis MJJ. Undernutrition enhances alcohol-induced hepatocyte proliferation in the liver of rats fed via total enteral nutrition. Am J Physiol293:G355–G364, 2007.
47.
Apte UM, McRee R, Ramaiah SK. Hepatocyte proliferation is the possible mechanism for the transient decrease in liver injury during steatosis stage of alcoholic liver disease. Toxicol Pathol32:567–576, 2004.
48.
Apte UM, Limaye L, Ramaiah SK, Vaidya VS, Bucci TJ, Warbritton A, Mehandale HM. Upregulated promitogenic signalling via cytokines and growth factors: potential mechanism of robust liver tissue repair in calorie-restricted rats upon hepatic challenge. Toxicol Sci69:448–459, 2002.
